Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Susquehanna Financial Group (SFG) is a premier global quantitative trading and investment firm, operating as the institutional broker-dealer arm of Susquehanna International Group (SIG). While not a biotechnology or pharmaceutical developer itself, SFG is a significant participant in the healthcare ecosystem through its specialized equity research and investment banking divisions. The firm provides institutional investors with deep fundamental analysis of clinical-stage biotechs, large-cap pharma, and medical technology companies. SFG is particularly renowned for its expertise in derivatives, options trading, and market making, which provides critical liquidity to healthcare-related equities. By combining technical scientific understanding with sophisticated financial modeling, the firm offers unique insights into the regulatory and commercial catalysts driving the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Susquehanna Financial Group.